Clinical Trials Directory

Trials / Terminated

TerminatedNCT03118479

Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)

Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators are doing this research study to look at the relationship between testosterone (the main sex hormone in men) and insulin (the hormone that controls blood sugar levels) in men with Idiopathic Hypogonadotropic Hypogonadism (IHH). The investigators hypothesize that normalizing testosterone levels in men with IHH enhances insulin sensitivity, reduces visceral fat, increases lean body mass, and improves the lipid profile.

Conditions

Interventions

TypeNameDescription
DRUGAnastrozole Pill10 mg of Anastrozole to be taken daily for 3 months.
DRUGTestosteroneAndrogel 7.5 g to be applied transdermally daily for 3 months.
DRUGPlacebo Oral TabletOne tablet to be taken daily for 3 months

Timeline

Start date
2010-05-01
Primary completion
2010-09-01
Completion
2010-09-01
First posted
2017-04-18
Last updated
2017-04-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03118479. Inclusion in this directory is not an endorsement.